Next Article in Journal
Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine
Next Article in Special Issue
In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies
Previous Article in Journal
Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer
Previous Article in Special Issue
Changing the Treatment Paradigm for Hepatocellular Carcinoma Using Atezolizumab plus Bevacizumab Combination Therapy
 
 
Review

Article Versions Notes

Cancers 2022, 14(4), 955; https://doi.org/10.3390/cancers14040955
Action Date Notes Link
article pdf uploaded. 14 February 2022 18:15 CET Version of Record https://www.mdpi.com/2072-6694/14/4/955/pdf-vor
article xml file uploaded 16 February 2022 10:10 CET Original file -
article xml uploaded. 16 February 2022 10:10 CET Update https://www.mdpi.com/2072-6694/14/4/955/xml
article pdf uploaded. 16 February 2022 10:10 CET Updated version of record https://www.mdpi.com/2072-6694/14/4/955/pdf
article html file updated 16 February 2022 10:29 CET Original file -
article html file updated 31 July 2022 18:06 CEST Update https://www.mdpi.com/2072-6694/14/4/955/html
Back to TopTop